QA: Nektar Therapeutics in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000906709_2014_Nektar_Therapeutics.pdf

Logs

Graph

Absolute values for 0000906709, Nektar Therapeutics

  xvar xval
0 AssetsCurrent 257,882,000
1 IntangibleAssetsNetIncludingGoodwill 76,501,000
2 PropertyPlantAndEquipmentNet 66,974,000
3 remainder_Assets 33,170,000
4 LiabilitiesCurrent 98,221,000
5 LiabilitiesNoncurrent 19,256,000
6 remainder_Liabilities 406,953,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 40,532,000
9 ResearchAndDevelopmentExpense 190,010,000
10 remainder_Expenses 40,754,000
11 remainder_Revenues 148,921,000
12 remainder_NetIncome -39,638,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 434,527,000
1 Liabilities 524,430,000
2 Expenses 271,296,000
3 Revenues 148,921,000
4 StockholdersEquity -89,903,000
5 NetIncome -162,013,000
6 ComprehensiveNetIncome -162,013,000
7 BaseVar 709,406,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.747
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time